Skip to main content
Log in

NTBC as palliative treatment in chronic tyrosinaemia type I

  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Holme E, Lindstedt S (1998) Tyrosinemia type I and NTBC (2-(2-nitro-4-tri- fluoromethylbenzoyl)-1,3-cyclohexanedione). J Inher Metab Dis 21: 507–517.

    PubMed  Google Scholar 

  • Lindstedt S, Holme E, Lock EA, Hjalmarsson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340: 813–817.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ros, J., Vilaseca, M.A., Lambruschini>, N. et al. NTBC as palliative treatment in chronic tyrosinaemia type I. J Inherit Metab Dis 22, 665–666 (1999). https://doi.org/10.1023/A:1005594416973

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005594416973

Keywords

Navigation